I agree BDZ, I was looking at this event (even tweeted it on stocktwits) yesterday and thinking it has some decent potential....and exactly for the reason you mention, the potential to get some positive ink (or the cyber equiviant) from Mr Zavoico and Dominique Verhelle. I decided to do some research on the two of them to see what I could find:

George Zavoico has a profile up on LifeSciences, (streetwise) and it includes some of his previous comments. Back in March of 2014 he was quite bullish on OMER, when it was trading in the $10 - $12 range. It then went on a sustained run up to around $25...

Even better than that was this quote on GLPG in November of 2014: "GLPG is notable and underappreciated". That was when the PPS was down around $15 and its now up over $50 and has been over $60 very recently.

He has some bad picks too....bullish comments made about other stocks that haven't performed. That's to be expected, I've looked at some analysts, and even top rated ones like Jim Birchenough with Wells Fargo (check tipranks) is only right a little more than half the time, but the winners are big and the losers aren't killers.

Now onto Mme Dominique Verhelle....checked her bio on linkedin. IMPRESSIVE, and she has a definite background in Epigenetics. She's worked at Pfizer too, as well as Celgene and was a post doctoral fellow (seems a sexist term in 2016) at the Univeristy of Califonia (SD).

https://www.linkedin.com/in/dominiqueverhelle

Check out her bona fides if you have a linkedin account. She's only been with Third Rock for four months, so I'm not finding anything on previous comments made about other companies....but hopefully Don and crew can impress her.